| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963615 | Vaccine | 2015 | 7 Pages |
Abstract
The EB66-derived H5N1 influenza vaccine adjuvanted with AS03 elicited a broad cross-reactive antibody response among H5N1 strains with acceptable reactogenicity. Therefore, KD-295 can be considered a useful pandemic and pre-pandemic influenza vaccine candidate.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Takeshi Naruse, Tadashi Fukuda, Tetsuro Tanabe, Munetaka Ichikawa, Yoshiaki Oda, Shinji Tochihara, Kazuhiko Kimachi, Yoichiro Kino, Kohji Ueda,